Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TPST
#4520
Tempest Therapeutics, Inc. Common Stock
2.145
0
USD
+0.23%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+0.23%
Mudança mensal
-4.03%
Mudança em 6 meses
-10.25%
Mudança anual
-10.25%
Fechamento anterior
2.140
0
Abrir
2.149
4
Bid
Ask
Mínimo
2.130
0
High
2.150
0
Volume
10
Mercados
Ações
Cuidados de saúde
TPST
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
2.93 M
1.1 M
1.62 M
3.41 M
7 M
14.34 M
—
Valuation ratios
Enterprise value
—
4.58 M
3.82 M
74.06 M
15.83 M
19.83 M
114.56 M
Price to earnings ratio
—
-0.71
-0.4
-2.31
-0.56
-0.23
-2.25
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
-0.77
-0.46
-2.49
-0.71
-0.22
-2.27
Price to book ratio
—
0.55
0.78
2.54
1.22
0.89
2.21
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.84
-0.39
-0.77
-0.57
-1.01
-1.55
-1.1
Return on equity %
-1.08
-0.78
-1.97
-1.1
-2.19
-3.94
-2.94
Return on invested capital %
-2 629.9
-856.53
-727.96
-676.5
-904
-731.61
-792.33
Gross margin %
100
—
—
—
—
—
—
Operating margin %
-11.99 K
—
—
—
—
—
—
EBITDA margin %
-5 048.67
—
—
—
—
—
—
Net margin %
-12.14 K
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
5.12
3.44
4.53
4.29
2.21
2.5
8.61
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
0.06
0.25
0.48
0.3
0.2
0.41
1.52
Debt to equity ratio
0.07
0.51
1.22
0.58
0.43
1.04
4.04
Long term debt to total assets ratio
0
0.21
0.23
0.12
0
0
0.13
Long term debt to total equity ratio
0
0.42
0.57
0.23
0
0
0.38
Per share metrics
Operating cash flow per share
—
-44.51
-17.49
-11.53
-7.69
-6.46
-3.9
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
31.79
12.45
6.5
1.9
1.67
5.24
Cash per share
—
88.88
17.58
16.54
7.05
1.86
7.71
Net current asset value per share
—
118.26
18.55
17.02
7.33
1.99
8.15
Tangible book value per share
—
61.94
10.19
11.29
4.46
1.61
5.23
Working capital per share
—
83.92
14.45
13.05
4.02
1.19
4.1
Book value per share
—
61.94
10.19
11.29
4.46
1.61
5.23
Notícias
New Strong Buy Stocks for April 10th
Tempest Therapeutics capta US$ 2 milhões em esforços restritos
Tempest Therapeutics reports complete response in myeloma trial
Ações da Tempest Therapeutics disparam após upgrade do H.C. Wainwright
Tempest Therapeutics stock surges after H.C. Wainwright upgrade
H.C. Wainwright eleva recomendação da Tempest Therapeutics para Compra com preço-alvo de US$ 11
H.C. Wainwright upgrades Tempest Therapeutics stock rating to Buy with $11 target
Tempest Therapeutics recebe notificação da Nasdaq sobre conformidade com reunião anual
Tempest Therapeutics receives Nasdaq notice for annual meeting compliance
Tempest Therapeutics conclui oferta direta registrada de US$ 4,25 milhões
Tempest Therapeutics closes $4.25 million registered direct offering
Ações da Tempest Therapeutics caem após oferta direta de US$ 4,25 milhões